✦ LIBER ✦

Adriamycin, BCNU plus cyclophosphamide (ABC) in advanced carcinoma of the head and neck

✍ Scribed by Cary A. Presant; Gary Ratkin; Carol Klahr; Carol Brown

Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 378 KB
Volume: 44
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197911)44:5<1571::aid-cncr2820440505>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclophosphamide, adriamycin, and cis-di

Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer

✍ Edward T. Creagan; Thomas R. Fleming; John H. Edmonson; James N. Ingle; John E. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 2 views

Bleomycin infusion followed by cyclophos

Bleomycin infusion followed by cyclophosphamide, methotrexate, and 5-fluorouracil in advanced squamous carcinoma of the head and neck

✍ Terry F. Plasse; Takao Ohnuma; Sandra Brooks; Edwardo Saponaro; James F. Holland 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB 👁 1 views

Adriamycin, 1,3-bis (2-chloroethyl)-1-ni

Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962), cyclophosphamide plus prednisone (ABC-P) in melphalan-resistant multiple myeloma

✍ Cary A. Presant; Carol Klahr 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

5-Fluorouracil, Cyclophosphamide, and Vi

5-Fluorouracil, Cyclophosphamide, and Vincristine for Adenoid Cystic Carcinoma of the Head and Neck

✍ Pierre L. Triozzi; Alton Brantley; Samuel Fisher; T. Boyce Cole; Ian Crocker; An 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views

A phase II study of adriamycin in previo

A phase II study of adriamycin in previously untreated squamous cell carcinoma of the head and neck

✍ Melody A. Cobleigh; James H. Hill; Patricia A. Gallagher; Lawrence J. Kukla; Tho 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

Twenty patients with squamous cell carcinoma of the head and neck (SCC H/N) were treated with Adriamycin (doxorubicin) at a dosage of 60 mg/m\* at 3-week intervals. No patient had received surgery, radiation, or chemotherapy before treatment with Adriamycin. Responses were observed in 44% of 18 eval

Adriamycin/cis-platinum/cyclophosphamide

Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland

✍ David S. Alberts; Michael R. Manning; Stanley W. Coulthard; Charles F. Koopmann 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB 👁 1 views